Shanghai Bao Pharmaceuticals

Bao Pharmaceuticals Co., Ltd. focuses on the development and commercialization of recombinant protein drugs and antibody drugs. They are currently building a modern GMP compliant biopharmaceutical industrialization base with a total investment of more than RMB 900 million in Shanghai. According to the design, the base will have multiple drug substance production lines for mammalian cell expression system and Escherichia coli/yeast expression system, covering drug product lines of aqueous solution for injection, lyophilized powder for injection and pre-filled disposable injection. It is expected that the first phase of the project will be put into operation within 2 years .